Guedj J - Search Results

1

Progress and Opportunities to Advance Clinical Cancer Therapeutics Using Tumor Dynamic Models.

Bruno R, Bottino D, de Alwis DP, Fojo AT, Guedj J, Liu C, Swanson KR, Zheng J, Zheng Y, Jin JY. Bruno R, et al. Among authors: guedj j. Clin Cancer Res. 2020 Apr 15;26(8):1787-1795. doi: 10.1158/1078-0432.CCR-19-0287. Epub 2019 Dec 23. Clin Cancer Res. 2020. PMID: 31871299 Free PMC article. Review.

2

Impact of variants of concern on SARS-CoV-2 viral dynamics in non-human primates.

Marc A, Marlin R, Donati F, Prague M, Kerioui M, Hérate C, Alexandre M, Dereuddre-Bosquet N, Bertrand J, Contreras V, Behillil S, Maisonnasse P, Van Der Werf S, Le Grand R, Guedj J. Marc A, et al. Among authors: guedj j. PLoS Comput Biol. 2023 Aug 9;19(8):e1010721. doi: 10.1371/journal.pcbi.1010721. eCollection 2023 Aug. PLoS Comput Biol. 2023. PMID: 37556476 Free PMC article.

3

Neutralizing Antibody Levels as a Correlate of Protection Against SARS-CoV-2 Infection: A Modeling Analysis.

Lingas G, Planas D, Péré H, Porrot F, Guivel-Benhassine F, Staropoli I, Duffy D, Chapuis N, Gobeaux C, Veyer D, Delaugerre C, Le Goff J, Getten P, Hadjadj J, Bellino A, Parfait B, Treluyer JM, Schwartz O, Guedj J, Kernéis S, Terrier B. Lingas G, et al. Among authors: guedj j. Clin Pharmacol Ther. 2024 Jan;115(1):86-94. doi: 10.1002/cpt.3069. Epub 2023 Oct 20. Clin Pharmacol Ther. 2024. PMID: 37795693

4

Association Between Tumor Size Kinetics and Survival in Patients With Urothelial Carcinoma Treated With Atezolizumab: Implication for Patient Follow-Up.

Tardivon C, Desmée S, Kerioui M, Bruno R, Wu B, Mentré F, Mercier F, Guedj J. Tardivon C, et al. Among authors: guedj j. Clin Pharmacol Ther. 2019 Oct;106(4):810-820. doi: 10.1002/cpt.1450. Epub 2019 Jul 5. Clin Pharmacol Ther. 2019. PMID: 30985002

5

Longitudinal analysis of organ-specific tumor lesion sizes in metastatic colorectal cancer patients receiving first line standard chemotherapy in combination with anti-angiogenic treatment.

Mercier F, Kerioui M, Desmée S, Guedj J, Krieter O, Bruno R. Mercier F, et al. Among authors: guedj j. J Pharmacokinet Pharmacodyn. 2020 Dec;47(6):613-625. doi: 10.1007/s10928-020-09714-z. Epub 2020 Aug 31. J Pharmacokinet Pharmacodyn. 2020. PMID: 32865652 Clinical Trial.

6

Bayesian inference using Hamiltonian Monte-Carlo algorithm for nonlinear joint modeling in the context of cancer immunotherapy.

Kerioui M, Mercier F, Bertrand J, Tardivon C, Bruno R, Guedj J, Desmée S. Kerioui M, et al. Among authors: guedj j. Stat Med. 2020 Dec 30;39(30):4853-4868. doi: 10.1002/sim.8756. Epub 2020 Oct 8. Stat Med. 2020. PMID: 33032368

7

Assessing the impact of organ-specific lesion dynamics on survival in patients with recurrent urothelial carcinoma treated with atezolizumab or chemotherapy.

Kerioui M, Desmée S, Mercier F, Lin A, Wu B, Jin JY, Shen X, Le Tourneau C, Bruno R, Guedj J. Kerioui M, et al. Among authors: guedj j. ESMO Open. 2022 Feb;7(1):100346. doi: 10.1016/j.esmoop.2021.100346. Epub 2021 Dec 23. ESMO Open. 2022. PMID: 34954496 Free PMC article.

8

Modelling the association between biomarkers and clinical outcome: An introduction to nonlinear joint models.

Kerioui M, Bertrand J, Bruno R, Mercier F, Guedj J, Desmée S. Kerioui M, et al. Among authors: guedj j. Br J Clin Pharmacol. 2022 Feb;88(4):1452-1463. doi: 10.1111/bcp.15200. Epub 2022 Feb 3. Br J Clin Pharmacol. 2022. PMID: 34993985 Free article. Review.

9

Assessing the Increased Variability in Individual Lesion Kinetics During Immunotherapy: Does It Exist, and Does It Matter?

Kerioui M, Bertrand J, Desmée S, Le Tourneau C, Mercier F, Bruno R, Guedj J. Kerioui M, et al. Among authors: guedj j. JCO Precis Oncol. 2023 Feb;7:e2200368. doi: 10.1200/PO.22.00368. JCO Precis Oncol. 2023. PMID: 36848611

10

Comparison of two-stage and joint TGI-OS modeling using data from six atezolizumab clinical studies in patients with metastatic non-small cell lung cancer.

Gonçalves A, Marchand M, Chan P, Jin JY, Guedj J, Bruno R. Gonçalves A, et al. Among authors: guedj j. CPT Pharmacometrics Syst Pharmacol. 2024 Jan;13(1):68-78. doi: 10.1002/psp4.13057. Epub 2023 Oct 25. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 37877248 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

171 results

Search Page